drugset / Trial / NCT00630903

PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides

NCT00630903

Phase 4 Terminated 54 enrolled Madrilenian Group of Cutaneous Lymphomas
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if combination of PUVA with interferon alpha is better than PUVA alone to treat mycosis fungoides stage Ia Ib or IIa.

Timeline

Start
2000-01
Primary completion
2003-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Interferon Protein / enzyme biologic 9e+06 iu
Comparator Methoxsalen Other / unclassified 0.6 mg/kg

Indications